Debate - Replacement of the Mitral Valve Under One Year of Age: Mechanical Valves Should Be Used

David G Lehenbauer1, James S Tweddell1, David S Winlaw1

  • 1Heart Institute and Department of Surgery, and the Division of Cardiothoracic Surgery, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Insights

Pediatric mitral valve replacement in infants under 1 year old has the highest mortality and poorest long-term outcomes. This review focuses on recent literature to guide valve selection and surgical techniques for neonatal and infant cases.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Surgery
  • Medical Literature Review

Background:

  • Mitral valve replacement in children younger than 1 year of age is a critical procedure.
  • This patient group faces the highest mortality and poorest long-term prognosis compared to other pediatric valve replacements.
  • Recent advancements necessitate a review of current practices.

Purpose of the Study:

  • To review the latest literature on mitral valve replacement in infants.
  • To provide insights into optimal valve choice and surgical techniques for neonatal and infant mitral valve replacement.
  • To highlight the challenges and outcomes associated with this high-risk procedure.

Main Methods:

  • Comprehensive literature search focusing on publications from the third millennium.
  • Analysis of studies reporting on mitral valve replacement in children younger than 1 year.
  • Special emphasis on neonatal and infant cases.

Main Results:

  • Identification of key trends and outcomes in infant mitral valve replacement.
  • Evaluation of different prosthetic valve options and their suitability for neonates and infants.
  • Analysis of surgical techniques and their impact on patient prognosis.

Conclusions:

  • Mitral valve replacement in infants remains a high-risk procedure with significant challenges.
  • Careful consideration of valve prosthesis and surgical technique is crucial for improving outcomes.
  • Further research is needed to optimize long-term results in this vulnerable population.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
68
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
76
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
107
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
113
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
111
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
122